IL6 and cancer: In patients with thromboinflammatory disorders, such as sepsis, cancer-associated thrombosis, or autoimmune vasculopathies, the dysregulated production of IL-6 and FgDPs may simultaneously promote a hypercoagulable state and maladaptive thrombopoiesis.